Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
BIOMARKER:
JAK2 V617F
i
Other names:
JTK10, THCYT3, JAK2, Janus Kinase 2, Tyrosine-Protein Kinase JAK2, JAK-2
Associations
(4)
News
Trials
C4 | Sensitive
D | Sensitive
C4 | Resistant
D | Resistant
Show legend
Include preclinical:
Drug categories
BCL Inhibitors
Epigenetics
Tyrosine Kinase Inhibitors
Immunotherapy
Serine-Threonine Kinase Inhibitors
Kinase Inhibitors
Other
Cancel
Acute Myelogenous Leukemia
venetoclax
C4
JAK2 V617F
|
Acute Myelogenous Leukemia
|
venetoclax
CPI-482
D
JAK2 V617F
|
Acute Myelogenous Leukemia
|
CPI-482
SB939 + pacritinib
D
JAK2 V617F
|
Acute Myelogenous Leukemia
|
SB939 + pacritinib
Josephin inhibitor
D
JAK2 V617F
|
Acute Myelogenous Leukemia
|
Josephin inhibitor
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
